Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Dec 19.
Published in final edited form as: Proc Am Control Conf. 2013:1964–1969. doi: 10.1109/acc.2013.6580123

Control Systems Engineering for Understanding and Optimizing Smoking Cessation Interventions*

Kevin P Timms 1, Daniel E Rivera 2, Linda M Collins 3, Megan E Piper 4
PMCID: PMC3868623  NIHMSID: NIHMS529528  PMID: 24362946

Abstract

Cigarette smoking remains a major public health issue. Despite a variety of treatment options, existing intervention protocols intended to support attempts to quit smoking have low success rates. An emerging treatment framework, referred to as adaptive interventions in behavioral health, addresses the chronic, relapsing nature of behavioral health disorders by tailoring the composition and dosage of intervention components to an individual’s changing needs over time. An important component of a rapid and effective adaptive smoking intervention is an understanding of the behavior change relationships that govern smoking behavior and an understanding of intervention components’ dynamic effects on these behavioral relationships. As traditional behavior models are static in nature, they cannot act as an effective basis for adaptive intervention design. In this article, behavioral data collected daily in a smoking cessation clinical trial is used in development of a dynamical systems model that describes smoking behavior change during cessation as a self-regulatory process. Drawing from control engineering principles, empirical models of smoking behavior are constructed to reflect this behavioral mechanism and help elucidate the case for a control-oriented approach to smoking intervention design.

I. INTRODUCTION

Behavioral interventions describe a class of preventive or therapeutic measures intended to reduce unhealthy behaviors or promote healthy ones [1]. Addressing a wide variety of public health issues such as substance abuse, obesity, and disease screening, these programs are pharmacological, behavioral (e.g., clinician counseling), or community-based (e.g., public smoking regulations) in nature [1], [2]. Due to a multitude of complicating factors such as multi-level and interacting sources of inter- and intra-individual variability (e.g., gene-environment interactions), effective design of behavioral interventions poses a major challenge [3], [4]; such challenges are compounded by the array of medical, ethical, and resource limitations demanded of interventions, as well as their experimental design and evaluation.

Behavioral interventions designed to promote cigarette smoking cessation are a major public health concern: in the U.S. alone, approximately 440,000 premature deaths and $157 billion in economic loss are attributed to smoking annually [5]. A significant obstacle in addressing this public health issue, though, is the limited utility of existing intervention protocols. Counseling alone, for example, has a reported successful quit rate below 15% and pharmaco-therapies (e.g., nicotine gum) have individual success rates below 35% [2]. These existing interventions are “fixed,” meaning all patients receive the same treatment protocol, which does not vary over the course of the intervention [3].

As an alternative, adaptive interventions have emerged as a promising strategy to address the chronic, relapsing nature of cigarette smoking [3], [2]. In adaptive interventions, treatments are tailored to individual patients over time and are defined according to decision rules, which specify intervention composition and dosage based on tailoring variables, such as a real-time patient-reported behaviors [3].

Traditionally, behavioral science models are static in nature. These models’ inability to describe behavioral and treatment dynamics means they cannot effectively inform adaptive intervention designs [6]. Toward a better understanding of intervention dynamics, computerized technologies offer a cost-effective means to collect intensive longitudinal data (ILD)—behavioral data collected at short intervals over time [6]. Figure 1 features such ILD, collected from participants in a University of Wisconsin smoking cessation clinical trial through personal digital assistants (PDAs) nightly. Specifically, Craving and Cigsmked (the number of cigarettes smoked per day), are shown for four data sets, averages for two of the study’s treatment groups and for two single participants from those groups [7]. As seen in Figure 1, the ability of ILD to capture behavioral dynamics offers the opportunity to examine smoking behavior change from a dynamical systems perspective [4], [8], [6]. From an engineering perspective, ILD used with system identification modeling techniques makes a connection between behavioral healthcare and control-guided intervention design [8], [9]. For example, empirical models that describe dynamical features, such as Craving’s inverse response or Cigsmked’s dramatic reduction immediately following quit and possible post-quit resumption in Fig. 1, could act as the plant model ((s)) in a smoking intervention algorithm [8]. More specifically, behavioral models developed from ILD measured daily lay the groundwork for a “just-in-time” adaptive intervention. In behavioral science settings, this describes adaptation implemented during the intervention—but with minutes to days of lag between real-time changes in tailoring variables and assignment of intervention adjustments [6].

Fig. 1.

Fig. 1

Craving and Cigsmked data collected daily in a UW-CTRI smoking cessation clinical trial. Four sets of signals are shown: averaged data for a group receiving bupropion and counseling as treatments (AC group; solid blue), averaged data for a group receiving neither drug nor counseling (PNc group; dashed green), a single subject from the AC group (dash-dot magenta), and a single subject from the PNc group (dotted red).

One of the most significant ways in which behavioral science can benefit from a control-oriented interpretation is in analysis of feedback and feedforward processes [8]. Self-regulation is a theory postulated in behavioral science [10], and has been theorized as a mechanism governing cigarette smoking maintenance. Specifically, the Nicotine Regulation Model and similar hypotheses suggest that smoking is done to maintain a blood nicotine or urge set point [11], [12]. Given that one of the greatest advantages of ILD is an opportunity to identify and describe self-regulatory and self-exciting relationships among behavioral variables [4], control systems engineering offers a mature methodology to comprehensively and parsimoniously characterize smoking cessation behavior change [8], [9].

Altogether, control systems engineering offers a comprehensive platform to address the feedback phenomena that enters at two levels in the understanding smoking behavior change and subsequent intervention design. Specifically, models of self-regulatory smoking cessation behavior change could be used in conjunction with controller design principles to produce an intervention algorithm that systematically defines a patient-specific treatment plan based on a patient’s previous behavior, changing needs, anticipated disturbances, and more. A significant advantage of such a control-theory-based-design is the opportunity to optimize for intervention efficacy and speed, while adhering to resource, medical, and other operational constraints [1], [8].

This paper is organized as follows: a University of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) smoking cessation clinical trial is first outlined [7]. Next, a model of smoking behavior change that features a feedback loop is presented and the UW-CTRI data is used to produce empirical smoking behavior change models. The self-regulation model is then discussed in the context of an intervention. Finally, conclusions are drawn and recommendations for future work are made.

II. SMOKING CESSATION CLINICAL TRIAL

ILD from a Transdisciplinary Tobacco Use Research Center-funded UW-CTRI study provide an experimental basis for evaluation of critical relationships among smoking behaviors. This clinical trial examined counseling and bupropion SR as smoking cessation aids: 101 participants received active drug and counseling (“AC” group), 100 received active drug and no counseling (“ANc”), 101 received placebo drug and counseling (“PC”), and 101 received placebo drug and no counseling (“PNc”). Those receiving active bupropion, which has been shown to alleviate withdrawal symptoms, including craving, took 150 mg starting one week prior to the planned quit date and 300 mg starting four days prior to the planned quit, allowing the drug to build up in the participants’ systems. The counseling protocol entailed eight counseling sessions that covered topics such as coping, motivation, and preventing relapse [7].

ILD was collected nightly through personal digital assistants (PDAs) for all participants in the form of Evening Reports (i.e., questionnaires); these self-reports recorded average levels of a variable over the day and actual smoking behaviors (e.g., Cigsmked, the total number of cigarettes smoked that day).

This article focuses on the relationship between Craving—the sum of Urge, Cigonmind, Thinksmk, and Bother questions, each measured on a 10-point Likert scale (1–11, No!!…Yes!!)—and Cigsmked. Two sets of group average Craving and Cigsmked signals are depicted in Fig. 2 for one week prior to quit through the first four post-quit weeks (solid blue, AC; dash-dot magenta, PNc). Fig. 2 indicates similar dynamic features for the group averages: Craving features distinct inverse response upon initiation of a quit attempt, and Cigsmked features a large, fast reduction in smoking, followed by a relatively small and slow resumption of smoking. Fig. 3 features data for one subject from the AC group (solid blue, with eight days of data imputed) and one from the PNc group (dash-dot magenta, seven days of missing data imputed). Although both single subject data sets are noisier than the group-average data shown, the AC subject’s Craving signal clearly features inverse response and Cigsmked has no resumption, suggesting a successful quit attempt. Conversely, the PNc subject features a dramatic reduction in Cigsmked and an increase in Craving upon quitting, but appears to fully resume smoking, as Craving and Cigsmked settle to approximately pre-quit levels.

Fig. 2.

Fig. 2

Plot of Craving and Cigsmked group average data (solid blue, AC; dash-dot magenta, PNc) and corresponding dynamical systems models (dashed green, AC; dotted red, PNc).

Fig. 3.

Fig. 3

Plot of Craving and Cigsmked data and dynamical systems models for two participants from the UW-CTRI study (solid blue, AC subject data; dashed green, AC subject model; dash-dot magenta, PNc subject data; dotted red, PNc subject model).

III. SMOKING BEHAVIOR SELF-REGULATION MODEL

Behavioral science’s particular interest in the concept of self-regulation for describing smoking behavior warrants a control engineering interpretation of smoking cessation [11], [12], [9]. Furthermore, estimation of such models is motivated by the fact that dynamic models describing smoking cessation as a process featuring mediation—a multivariable causal relationship central to mechanistic modeling in the social sciences—do not fully describe a Craving-Cigsmked interrelationship captured in the UW-CTRI ILD [9].

The solid lines in Fig. 4 feature a block diagram depicting a novel mechanism that describes smoking cessation behavior change as a feedback process. In this model, Craving is directly related to Cigsmked by P(s), and Cigsmked itself is composed of two pathways, a quit pathway and a feedback pathway. The quit pathway’s contribution is the output of Pd (s), which accepts a unit step input, Quit(s), that corresponds to the transition from not attempting to quit smoking to attempting to quit. The feedback pathway’s contribution is the output of C(s), a craving self-regulator, which accepts e—the deviation between a craving set point, r, and the time-varying Craving signal—as the input. This proposed model describes an intuitive relationship: smoking is governed by the difference between an individual’s biologically and/or psychologically-determined perceived need to smoke (r), and time-varying craving for cigarettes, which itself is a result of smoking; an attempt to quit smoking is effectively a disturbance on this regulatory process.

Fig. 4.

Fig. 4

Block diagram depicting a smoking behavior change mechanism in which a Craving-Cigsmked interrelationship is described by self-regulation (solid); a hypothetical treatment mechanism (dashed).

The closed-loop transfer functions corresponding to the solid lines in Fig. 4 are,

Craving=(PC1+PC)r+(PPd1+PC)Quit (1)
Cigsmked=(C1+PC)r+(Pd1+PC)Quit (2)

With the UW-CTRI ILD and (1) and (2), empirical model development becomes a closed-loop identification problem. For this, P(s) is estimated as a single-input-single-output system with Cigsmked as the input and Craving as the output. Pd(s) and C(s) are estimated as a multi-input-single-output system with Quit and e (=r – Craving) as inputs and Cigsmked as the output.

In evaluating the proposed mechanism, a nomothetic (i.e., group-focused) perspective is employed to develop the empirical models using group average ILD from the UW-CTRI study. Doing so can provide generalizable insight into behavioral relationships. P(s), Pd(s), and C(s) are estimated using the PEM functionality and process models notation in Matlab’s System Identification Toolbox. In this analysis, the goodness-of-fit metric (0–100% scale) is calculated as,

Fit[%]=100(1-y(t)-y(t)2y(t)-y¯2) (3)

where y(t) is the data, ȳ is the mean value of the 36-day data signal to which the model is fit, and (t) is the simulated output. In the iterative estimation process used here, transfer function structures were varied and the resulting candidate models simulated. Validity of the resulting empirical models were evaluated for predictive ability, parameter realizability, and transfer function parsimony. The appropriate r was determined during estimation, as several constant r values and linear functions were tested.

The results of this estimation are found in Table I and the associated simulations for the AC and PNc groups are found in Fig. 2 (dashed green, AC; dotted red, PNc). Although five distinct stages of smoking cessation have been theorized [13], which may suggest r may vary over time, the pre-quit baseline Craving level appears to be the most appropriate r over the post-quit time period modeled. The appropriate transfer function structures that correspond to the parameters estimated using the group average ILD in Table I were determined to be,

TABLE I.

Feedback model parameter estimates and goodness-of-fits.

Treatment: AC ANc PC PNc AC PNc
Data Set: Avg Avg Avg Avg Sgl Sgl
 Craving
 Fit [%] 87.32 77.65 77.51 62.25 66.90 57.59
Cigsmked
 Fit [%] 89.16 83.03 91.44 84.12 77.09 62.99
 Craving
 Set. T. 35.69 35.91 35.82 35.90 26.34 33.87
Cigsmked
 Set. T. 34.56 35.26 35.60 35.29 10.64 33.86
P(s) K1 0.77 0.74 0.50 0.52 1.57 −2.21
P(s) τa1 −1.99 −3.76 −14.34 −21.90 −3.05 3.45
P(s) τ1 8.22 14.23 18.70 26.75 6.88 10.76
C(s) Kc 0.08 0.23 0.20 0.30 −0.01 −6.25
C(s) τc 4.59 2.89 0.42 1.89 1.29 95.53
Pd (s) Kd −15.01 −13.13 −13.50 −10.24 −13.05 −15.99
P(s)=K1(τas+1)(τ1s+1) (4)
Pd(s)=Kd (5)
C(s)=KC(τc1s+1) (6)

As documented in Table I, high goodness-of-fit values are achieved for the four groups, which all feature comparable dynamic phenomena. This suggests that the self-regulatory process depicted as the solid lines in Fig. 4 appropriately represents a fundamental relationship between craving and daily smoking. This behavior change mechanism is supported by the fact that models where Craving and Cigsmked are reversed have no predictive ability. Interestingly, we find that Pd(s) models the dramatic reduction in daily smoking upon quitting, while the C(s) pathway models the resumption in smoking. More importantly, the C(s) transfer function structure indicates that across a population, a smoker’s craving self-regulator behaves as a Proportional-with-Filter controller. Furthermore, it is known in dynamical systems that a model with a zero term can come from two parallel first order models. For the group average models, the first subprocess, P1(s), would have a negative gain and a smaller speed of response compared to that for a second subprocess, P2(s), which would have a positive gain. Craving’s initial increase would reflect the fast contribution of the negative-gained function as it accepts the large decrease in Cigsmked upon quitting, while Craving’s settling to below pre-quit levels would reflect the slow contribution of the positive-gained function as it accepts the increasing Cigsmked values (resumption). The dual nature of this possible underlying P(s) phenomena is appealing considering the two paired components of nicotine addiction (biochemical and conditioning processes), and the impulsive and executive neurological systems that manage immediate and delayed gratification motivations, respectively, which compete during smoking cessation [14].

Ideally, assignment and adjustment of intervention components would be based on patient-specific models of smoking behavior change. This motivated development of empirical models for the two UW-CTRI single subject examples. Estimation and validation of these models involved the same procedure as before, but r was assumed to be the baseline craving level. The model structures that describe the group average dynamics adequately describe the single subject dynamics as well. The corresponding parameter estimates and simulations are in Table I and Fig. 3, respectively.

As the PNc subject’s K1 estimate is negative, the parallel subprocesses that may make up P(s) would have a relationship different than that described for the group average models. Specifically, both subprocess gains would be negative, corresponding to the increase in Craving that results from the step-like decrease in Cigsmked on the quit date and the settling of Craving to approximately pre-quit values that results from the post-quit increase in Cigsmked. While still adequately described as a Proportional-with-Filter controller, the PNc subject’s C(s) reflects this subject’s significant resumption in daily smoking. The resumption in Cigsmked resulting from this subject’s craving self-regulator highlights the chronic and relapsing nature of nicotine addiction, which may be effectively managed by interventions that are adaptive in nature [3], [8].

Examining Table I, the single subject models have lower goodness-of-fit values than their group average counterparts. These lower values represent a significant and expected challenge in single subject modeling; the reliability of single subject models is a function of the quality of source data, which may be noisy, require imputation of missing values, and more. The AC single subject’s Cigsmked baseline exemplifies such concerns; the baseline appears to be non-stationary, but this is largely a consequence of the imputation of several consecutive days of missing data.

Although an adaptive smoking intervention algorithm would ideally be used in conjunction with accurate patient-specific behavior change models, identification of these models would require data collected during previous quit attempts. While design of a “patient-friendly” experiment could mitigate some single subject data quality issues, suggesting that a patient attempt to quit smoking for the purposes of reliable model estimation is largely impractical. However, a model of the smoking cessation process that reflects a behavioral predisposition to quit attempt failure can inform intervention design. The following expressions represent such a failed quit process for a hypothetical patient:

P(s)=-2.46(3.89s+1)(15.05s+1) (7)
Pd(s)=-20.29(1.77s+1) (8)
C(s)=-20.07(90.92s+1) (9)

In the context of the closed-loop smoking cessation process depicted as the solid lines in Figure 4, Equations (7), (8), and (9) represent a hypothetical patient’s dynamics: the mathematical structures adhere to those that adequately describe the clinical trial data, but the parameters reflect a behavioral relationship that inherently leads to failure of an attempt to quit smoking. Specifically, the parameters describe dynamics in which Craving increases upon a quit-induced reduction in Cigsmked, but both Craving and Cigsmked settle to approximately pre-quit levels. Selection of these parameters was guided by the apparent quit attempt failure in the previously described PNc single subject, although the PNc subject’s steady-state Craving and Cigsmked models settle at values unequal to pre-quit levels.

IV. TOWARD A CLOSED-LOOP INTERVENTION

With an improved understanding of the fundamental smoking cessation behavioral mechanism, an analysis of medication effects is of interest. Here, a treatment scenario is modeled in which representative behavioral dynamics, i.e., model of a failed cessation attempt, are intervened upon to result in cessation success. This is a precursor to development of an optimal treatment strategy. In this section, one candidate pharmacological intervention mechanism that features dual models of action is examined.

A hypothetical pharmacological treatment is depicted as the dashed lines in Fig. 4. For this, PIC(s) directly affects time-varying craving levels, which many existing smoking cessation medications are said to do, and PIr (s) affects r, which represents the treatment interfering with addiction mechanisms [15]. Fig. 4’s closed-loop transfer functions are,

Craving=(PIC+PIrPC1+PC)uI+(PPd1+PC)Quit (10)
Cigsmked=((PIr-PIC)C1+PC)uI+(Pd1+PC)Quit (11)

The treatment mechanism depicted in Fig. 4 is hypothetical, representing one possible relationship by which self-regulated smoking behavior change is affected by a pharmacological intervention. To examine this hypothetical intervention, simulations were conducted in Matlab’s Simulink environment where Equations (7), (8), and (9) represented the fundamental behavioral relationship. As the dynamic treatment mechanism discussed is not intended to reflect pharmaco-kinetics or pharmaco-dynamics of any specific pharmacological smoking intervention, selection of the PIC(s) and PIr(s) transfer function structures and parameters was guided by general knowledge of how a behavioral process predisposed to cessation failure could be altered for success, but were largely determined through trial-and-error. In identifying the intervention transfer function structures and parameters that lead to a more successful quit, uI was set as a unit step occurring on the quit date; this corresponds to a fixed intervention protocol that becomes effective on the quit date. A candidate set of transfer functions promoting a successful quit are,

PIr(s)=-7.5(5s+1) (12)
PIC(s)=-43(10s+1) (13)

These transfer functions suggest the dual medication effects could independently (regardless of a quit attempt) facilitate a gradual decrease in r, an intuitive medication effect, and a decrease in Craving. Using the hypothetical patient’s P(s), Pd (s), and C(s) expressions and the PIr (s) and PIC (s) intervention models, Fig. 5 features 60 days of simulated Craving and Cigsmked results of this fixed intervention (intervention, dash-dot blue; intervention-free, dashed green).

Fig. 5.

Fig. 5

Two months of simulated Craving and Cigsmked outputs for two cases with the quit attempt beginning on day 7 (coded as step, solid black): no intervention, dashed green; intervention, which is said to become effective on the quit date (coded as a step), dash-dot blue.

Favorable behavioral dynamics are achieved in both Craving and Cigsmked in the simulation. Specifically, Craving decreases by approximately 30%, and the max peak is now 25.4, more than 10 points below the intervention-free simulation, and only about one point above the pre-quit level. Examining the Cigsmked simulation, this fixed intervention also appears to reach and maintain a successful quit.

Generally, these simulations illustrate that a fixed intervention protocol relying on a pharmacological smoking treatment that features dual modes of action can dynamically promote a successful quit within a behavioral system that otherwise leads to a failed cessation attempt.

The intervention mechanism presented may be suboptimal. First, the dynamic effects of existing pharmacological interventions have not been characterized according to the mechanism depicted in Fig. 4. Furthermore, inter-individual variability in the self-regulatory relationship (person-to-person variation in P(s), Pd (s), and C(s) parameters), response to medication (person-to-person variation in PIr (s) and PIC (s) parameters), and unknown disturbances (exogenous variables, such as environmental smoking cues) suggest a fixed intervention similar to that simulated in Fig. 5 would be suboptimal, at least in terms of resource use. As identification of reliable patient-specific models that account for such variability is prohibitively challenging, the case for an adaptive intervention remains clear, as is the utility of controller design principles in optimizing such interventions. Specifically, controller design principles could be used in conjunction with the self-regulatory behavioral model in a manner similar to that in Fig. 6. Design of such a controller could rely on medication to promote favorable signal shapes for both Cigsmked and Craving; while a Cigsmked = 0 set point would be prioritized, including a second set point for Craving, or treating this as an associated variable, could promote post-quit Craving reduction. Drawing from additional knowledge of relationships between behavioral, biological, and environmental variables (i.e., disturbances), a controller featuring both feedback and feedforward control is particularly appealing. For example, accounting for Quit as a forecasted measured disturbance may help mitigate negative behavioral effects of quitting; similarly, anticipating measured disturbances, such as an exogenous Stress signal, may also help manage the conditions promoting relapse. Altogether, a Hybrid Model Predictive Control (HMPC) strategy should be employed. Considering the human health focus of this problem, the ability of HMPC to manage the discrete nature of manipulated variables (i.e., pre-determined medication dosages) and hard- and soft-constraints makes it an advantageous intervention framework [16]. Furthermore, an HMPC design method could be used to provide insight into aspects of intervention optimality; notably, questions regarding necessary amounts of intervention components (e.g., medication dosage), duration of the overall treatment, and scheduling of alternate treatment components (e.g., combined medication and counseling) could be explored. Development of such an intervention algorithm could also inform design of novel clinical trials that more effectively measure and evaluate the dynamics and optimality of smoking cessation treatment strategies.

Fig. 6.

Fig. 6

Proposed framework for an optimized adaptive smoking intervention.

V. CONCLUSIONS AND RECOMMENDATIONS

In this paper, a control-oriented approach to the study of smoking cessation is employed. In doing so, the utility of such a perspective in this behavioral context is highlighted by use of ILD to produce parsimonious descriptions of self-regulation within smoking cessation. Models of this nature offer more comprehensive descriptions of smoking behavior as compared to traditional, static behavioral models. To develop an optimized smoking cessation intervention, a second level of feedback could be introduced to this problem. Specifically, an adaptive smoking intervention algorithm could be constructed to optimize and personalize cessation therapies. An algorithm of this nature could feature both feedback and feedforward components and would likely benefit from an HMPC framework.

Footnotes

*

This work was supported by an award from the American Heart Association, the Office of Behavioral and Social Sciences Research (OBSSR) of the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA) through grants K25 DA021173, R21 DA024266, and P50 DA10075.

Contributor Information

Kevin P. Timms, Email: ktimms@asu.edu.

Daniel E. Rivera, Email: daniel.rivera@asu.edu.

Linda M. Collins, Email: lmcollins@psu.edu.

Megan E. Piper, Email: MEP@ctri.medicine.wisc.edu.

References

  • 1.Rivera DE, Pew MD, Collins LM. Using engineering control principles to inform the design of adaptive interventions: A conceptual introduction. Drug and Alcohol Dependence. 2007;88(Supplement 2):S31–S40. doi: 10.1016/j.drugalcdep.2006.10.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tobacco Use and Dependence Guideline Panel. A clinical practice guideline for treating tobacco use and dependence: 2008 update. American Journal of Preventive Medicine. 2008;35(2):158–176. doi: 10.1016/j.amepre.2008.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prevention Science. 2004;5(3):185–196. doi: 10.1023/b:prev.0000037641.26017.00. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Collins LM. Analysis of longitudinal data: The integration of theoretical model, temporal design, and statistical model. Annual Review of Psychology. 2006;57(1):505–528. doi: 10.1146/annurev.psych.57.102904.190146. [DOI] [PubMed] [Google Scholar]
  • 5.Killeen PR. Markov model of smoking cessation. PNAS. 2011;108(Supplement 3)(37):15549–15556. doi: 10.1073/pnas.1011277108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Riley WT, Rivera DE, Atienza AA, Nilsen W, Allison SM, Mermelstein R. Health behavior models in the age of mobile interventions: Are our theories up to the task? Translational Behavioral Medicine. 2011;1(1):53–71. doi: 10.1007/s13142-011-0021-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Fiore MC, Baker TB. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. Nicotine and Tobacco Research. 2008a;10(4):717–729. doi: 10.1080/14622200801968343. [DOI] [PubMed] [Google Scholar]
  • 8.Rivera DE. Optimized behavioral interventions: What does system identification and control systems engineering have to offer?. 16th IFAC Symposium on System Identification; Brussels, Belgium. 2012. pp. 882–893. [Google Scholar]
  • 9.Timms KP, Rivera DE, Collins LM, Piper ME. System identification modeling of a smoking cessation intervention. 16th IFAC Symposium on System Identification; Brussels, Belgium. 2012. pp. 786–791. [Google Scholar]
  • 10.Carver CS, Scheier MF. On the Self-Regulation of Behavior. Cambridge University Press; New York, New York: 1998. [Google Scholar]
  • 11.Velicer WF, Redding CA, Richmond RL, Greeley J, Swift W. A time series investigation of three nicotine regulation models. Addictive Behaviors. 1992;17(4):325–345. doi: 10.1016/0306-4603(92)90039-x. [DOI] [PubMed] [Google Scholar]
  • 12.Walls TA, Rivera DE. Control engineering-based approaches to modeling substance abuse data. Washington, D.C. May 2009; 17th Annual Meeting of the Society for Prevention Research. [Google Scholar]
  • 13.Velicer WF, Hughes SL, Fava JL, Prochaska JO. An empirical typology of subjects within stage of change. Addictive Behaviors. 1995;20(3):299–320. doi: 10.1016/0306-4603(94)00069-b. [DOI] [PubMed] [Google Scholar]
  • 14.Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: Competing neural systems and temporal discounting processes. Drug and Alcohol Dependence. 2007;90(1):S85–S91. doi: 10.1016/j.drugalcdep.2006.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.West R, Baker CL, Cappelleri JC, Bushmakin AG. Effect of Varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology. 2008;197:371–377. doi: 10.1007/s00213-007-1041-3. [DOI] [PubMed] [Google Scholar]
  • 16.Nandola NN, Rivera DE. An improved formulation of Hybrid Model Predictive Control with application to production-inventory systems. IEEE Transactions on Control Systems Technology. 2013;21(1):121–135. doi: 10.1109/TCST.2011.2177525. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES